Drugs / Choriomon
Choriomon
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy4 trials | ||||||
| Phase 3 | NCT04537078 Comparator | Sep 2020 → Mar 2021 | female infertility | El Shatby University Hospital for Obstetrics and Gynecology | Completed | No outcome recorded |
| Phase 3 | NCT02470169 Comparator | Jun 2015 → Jun 2017 | infertility disorder | Cairo University | Unknown | No outcome recorded |
| Phase 3 | NCT02461173 Comparator | Jun 2015 → May 2017 | infertility disorder | Cairo University | Unknown | No outcome recorded |
| Phase 3 | NCT02469805 Comparator | Jun 2015 → Jun 2018 | infertility disorder | Cairo University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Choriomon | “HCG triggering (Choriomon, IBSA, Lugano, Switzerland) in a dose of 10,000 IU” NCT04537078 ↗ |
| Known as | hCG | “Administration of 10000 IU of human chorionic gonadotropin (hCG; Choriomon®, IBSA) when at least 2 follicles measuring 18 mm are observed during vaginal ultrasound and is...” NCT02469805 ↗2“Administration of 10000 IU of human chorionic gonadotropin (hCG; Choriomon®, IBSA) when at least 2 follicles measuring 18 mm are observed during vaginal ultrasound and is...” NCT02470169 ↗ “human chorionic gonadotropin (hCG; Choriomon®, IBSA)” NCT02461173 ↗ |
| Known as | human chorionic gonadotropin | “Administration of 10000 IU of human chorionic gonadotropin (hCG; Choriomon®, IBSA) when at least 2 follicles measuring 18 mm are observed during vaginal ultrasound and is...” NCT02469805 ↗1“Administration of 10000 IU of human chorionic gonadotropin (hCG; Choriomon®, IBSA) when at least 2 follicles measuring 18 mm are observed during vaginal ultrasound and is...” NCT02470169 ↗ |
| Modality | Protein / enzyme biologic | “human chorionic gonadotropin” NCT02469805 ↗ |